Mardi Dier

Insider Reports History

Entity
Individual
Location
C/O Acelyrin, Inc., 4149 Liberty Canyon Rd., Agoura Hills, CA
Signature
/s/ Krishna Vaddi, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mardi Dier:

Stock Role Class Num Shares Value Price $ Report Date Ownership
MADRIGAL PHARMACEUTICALS, INC. SVP and CFO Common Stock 8.88K $2.16M $243.92 Mar 11, 2024 Direct
Ultragenyx Pharmaceutical Inc. CFO & Executive Vice President Common Stock 66.7K $1.4M $21.00 Oct 14, 2022 Direct
Adamas Pharmaceuticals Inc Director Common Stock 10K $51.6K $5.16 Jun 2, 2021 Direct
ACELYRIN, Inc. CFO and CBO Common Stock 5.56K $41.2K $7.41 May 9, 2023 Direct
ACELYRIN, Inc. CFO and CBO Common Stock 875 $6.48K $7.41 May 9, 2023 Indirect
ACELYRIN, Inc. CFO and CBO Employee Stock Option (right to buy) 85.2K May 9, 2023 Direct
Oric Pharmaceuticals, Inc. Director Stock Option (right to buy) 25.6K Jun 12, 2024 Direct
Prelude Therapeutics Inc Director Director Stock Option (Right to Buy) 23.5K Jun 14, 2024 Direct
Adamas Pharmaceuticals Inc Director Stock Option (Right to Buy) 10K Jun 2, 2021 Direct

Insider Reports Filed by Mardi Dier

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PRLD Prelude Therapeutics Inc Jun 14, 2024 1 $0 4 Jun 18, 2024 Director
ORIC Oric Pharmaceuticals, Inc. Jun 12, 2024 1 $0 4 Jun 14, 2024 Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Mar 11, 2024 0 $0 3 Mar 21, 2024 SVP and CFO
PRLD Prelude Therapeutics Inc Jun 16, 2023 1 $0 4 Jun 21, 2023 Director
ORIC Oric Pharmaceuticals, Inc. Jun 14, 2023 1 $0 4 Jun 15, 2023 Director
SLRN ACELYRIN, Inc. May 9, 2023 7 $132K 4 May 11, 2023 CFO and CBO
SLRN ACELYRIN, Inc. May 4, 2023 1 $0 4 May 4, 2023 CFO and CBO
SLRN ACELYRIN, Inc. May 4, 2023 0 $0 3 May 4, 2023 CFO and CBO
RARE Ultragenyx Pharmaceutical Inc. Oct 14, 2022 1 -$65.4K 4 Oct 17, 2022 CFO & Executive Vice President
RARE Ultragenyx Pharmaceutical Inc. Oct 12, 2022 1 -$133K 4 Oct 14, 2022 CFO & Executive Vice President
RARE Ultragenyx Pharmaceutical Inc. Sep 16, 2022 1 $0 4 Sep 19, 2022 CFO & Executive Vice President
PRLD Prelude Therapeutics Inc Jun 17, 2022 1 $0 4 Jun 22, 2022 Director
ORIC Oric Pharmaceuticals, Inc. Jun 17, 2022 1 $0 4 Jun 17, 2022 Director
RARE Ultragenyx Pharmaceutical Inc. Mar 1, 2022 4 -$62.7K 4 Mar 3, 2022 CFO & Executive Vice President
RARE Ultragenyx Pharmaceutical Inc. Oct 12, 2021 2 -$553K 4 Oct 14, 2021 CFO & Executive Vice President
PRLD Prelude Therapeutics Inc Jun 18, 2021 1 $0 4 Jun 22, 2021 Director
ORIC Oric Pharmaceuticals, Inc. Jun 16, 2021 1 $0 4 Jun 17, 2021 Director
ADMS Adamas Pharmaceuticals Inc Jun 2, 2021 2 $0 4 Jun 4, 2021 Director